ZJYL
Jin Medical International Ltd.Price
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
- R Jun 29 Jin Medical International Ltd. (ZJYL) filed proxy materials for an E…
- R Jul 20 Shareholders approved a massive authorized share capital increase fr…
- X Jul 31 Short interest falls 79.5% to 3.3K
- X Aug 14 Short interest jumps 4358.3% to 147.9K
- X Aug 31 Short interest falls 58.4% to 61.5K
- X Sep 15 Short interest jumps 25.6% to 77.3K
- R Sep 24 Jin Medical International Ltd. completed the acquisition of Huaxia Q…
- R Sep 25 CEO and Chairman Erqi Wang files a final amendment to Schedule 13D,…
Signal stack
Where each data set points today.
- Short sellersSTEADY
Short interest −9.4% to 70.0K shares. 1.5 days to cover, ≈0.0% of shares.
- TrendRANGE
13% below its 50-day average.
Who's buying
13F| Top holder | Shares | Value |
|---|---|---|
| HRT FINANCIAL LP | 15,662 | $28.0K |
| OSAIC HOLDINGS, INC. | 3,100 | $5.6K |
| UBS Group AG | 971 | $1.8K |
Quarterly 13F filings are due 45 days after each quarter ends.
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | — | — | — | $0.00 |
| Next Q | — | — | — | $0.00 |
| Current FY | — | — | — | $0.00 |
| Next FY | — | — | — | $0.00 |
Short side
FINRA· Sep 30, 2026SecBot reports
8 filings · 0 bullish · 6 bearish · 2 neutral- BEARISH SC 13D/ASep 25, 2026
CEO and Chairman Erqi Wang files a final amendment to Schedule 13D, reporting that his beneficial…
The massive share issuance for an acquisition and advisory fees signals potential overpayment or distressed financing. Monitor the acquisition target's quality and any subsequent insider selling…
- BEARISH 6-KSep 24, 2026
Jin Medical International Ltd. completed the acquisition of Huaxia Qiying (Beijing) Technology…
The massive share issuance (over 50% dilution) and the incomplete Kangma Equity transfer create significant overhang and uncertainty. Monitor the October 31, 2026 deadline for the Kangma transfer —…
- BEARISH PRESS-RELEASEAug 4, 2026
Jin Medical International reported a 9.7% YoY revenue decline to $8.9M for H1 fiscal 2026…
Revenue declined and the company posted a net loss, with key headwinds from FX and lost electric scooter sales unlikely to reverse quickly. Monitor the next quarterly filing for evidence of…
- BEARISH 6-KJul 20, 2026
Shareholders approved a massive authorized share capital increase from 50M to 15B shares, a 10.6x…
Expect severe downward pressure on ZJYL as the market prices in the massive dilution from the 64.2M-share issuance and the authorized share count increase. The entrenchment of CEO control and the…
All ZJYL filing & press-release reports (8)
- SC 13D/A reportSep 25, 2026
- 6-K reportSep 24, 2026
- PRESS-RELEASE reportAug 4, 2026
- 6-K reportJul 20, 2026
- 6-K reportJun 29, 2026
- 6-K reportJun 4, 2026
- 3 reportApr 27, 2026
- 6-K reportApr 7, 2026